Akebia Therapeutics, Inc. (AKBA) stock
AKBANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.40−0.05 (-10.74%)
Close on Nov 17, 2026Market cap $110.95MP/E –Yield –
Akebia Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Akebia Therapeutics's market cap was $155.90M on Nov 11, 2026, against $419.06M a year earlier. Over the last 5 years it ranged from $46.75M to $964.16M, with a median of $289.05M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $155.90M | -63.5% |
| 2025 | Dec 31, 2025 | $427.01M | +6.2% |
| 2024 | Dec 31, 2024 | $401.93M | +72.1% |
| 2023 | Dec 29, 2023 | $233.51M | +120.0% |
| 2022 | Dec 30, 2022 | $106.14M | -73.1% |
| 2021 | Dec 31, 2021 | $394.49M | -1.7% |
| 2020 | Dec 31, 2020 | $401.32M | -46.6% |
| 2019 | Dec 31, 2019 | $751.22M | +138.1% |
| 2018 | Dec 31, 2018 | $315.47M | -55.1% |
| 2017 | Dec 29, 2017 | $702.43M | +76.4% |
| 2016 | Dec 30, 2016 | $398.22M | +2.0% |
| 2015 | Dec 31, 2015 | $390.42M | +65.2% |
| 2014 | Dec 31, 2014 | $236.29M | – |
See a number that looks wrong?